Cargando…
Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with pulmonary hemorrhage is rare in childhood. Standard treatment includes corticosteroids and cyclophosphamide (CYC), which is associated with a high level of toxicity. We report a white female with ANCA positive pulmonary hem...
Autores principales: | Baird, Emily M, Lehman, Thomas JA, Worgall, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215638/ https://www.ncbi.nlm.nih.gov/pubmed/22032441 http://dx.doi.org/10.1186/1546-0096-9-33 |
Ejemplares similares
-
Anti-Neutrophilic Cytoplasmic Antibody (ANCA) Vasculitis Presented as Pulmonary Hemorrhage in a Positive COVID-19 Patient: A Case Report
por: Hussein, Albadr, et al.
Publicado: (2020) -
Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
por: Salama, Alan D.
Publicado: (2019) -
Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody(ANCA)-associated vasculitis
por: Tsukui, Daisuke, et al.
Publicado: (2021) -
Hydralazine-Induced Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
por: Echevarria, Victoria, et al.
Publicado: (2023) -
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
por: Cortazar, Frank B., et al.
Publicado: (2017)